Major Depressive Disorder

Latest News

FDA approved
Esketamine CIII Nasal Spray: First and Only Monotherapy for Treatment-Resistant Depression

January 21st 2025

The FDA has approved the supplemental New Drug Application for Spravato, the first and only monotherapy for adults with treatment-resistant depression.

brain research
Upcoming Research Related to DLX-001 for Major Depressive Disorder

January 17th 2025

pills
Why We Need a New Class of Antidepressants

January 16th 2025

treatment resistant depression
Treatment-Resistant Depression: Which Patients Respond to Ketamine vs ECT?

January 15th 2025

brain
Separating the Therapeutic From the Hallucinatory: A Look at a Novel Neuroplastogen for MDD

January 15th 2025

Video Series
Video Interviews
Podcasts
mental health podcasts
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.